Janssen is dedicated to making INVOKANA® affordable and accessible for all patients. INVOKANA® is accessible nationwide, with broad* coverage for commercial patients and coverage for the majority† of Medicare Part D patients.1
To see the coverage information for your patients, enter your ZIP code. Your results will appear below.
The information provided is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. This information is presented for informational purposes only and is not intended to provide reimbursement or legal advice, nor does it promise or guarantee coverage, levels of reimbursement, payment, or charge. It is not intended to increase or maximize reimbursement by any payer. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this information, the information may not be as current or comprehensive when you view it. Please contact the plan for more information about coverage or any restrictions or prerequisites that may apply. We strongly recommend you consult the payer organization for its reimbursement policies. All information is subject to change.
*"Broad" means that >65% of covered lives have coverage for INVOKANA®.
†"Majority" means that ≥51% of covered lives have coverage for INVOKANA®.
These percentages may not represent 100% of formulary lives due to data limitations.